CN113024536A - 含嘧啶-哌嗪环的5-氨基噻唑甲酰胺类化合物及其制备方法和用途 - Google Patents
含嘧啶-哌嗪环的5-氨基噻唑甲酰胺类化合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN113024536A CN113024536A CN202110278281.7A CN202110278281A CN113024536A CN 113024536 A CN113024536 A CN 113024536A CN 202110278281 A CN202110278281 A CN 202110278281A CN 113024536 A CN113024536 A CN 113024536A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- solvent
- aminothiazole
- boc amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110278281.7A CN113024536B (zh) | 2021-03-12 | 2021-03-12 | 含嘧啶-哌嗪环的5-氨基噻唑甲酰胺类化合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110278281.7A CN113024536B (zh) | 2021-03-12 | 2021-03-12 | 含嘧啶-哌嗪环的5-氨基噻唑甲酰胺类化合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113024536A true CN113024536A (zh) | 2021-06-25 |
CN113024536B CN113024536B (zh) | 2022-05-27 |
Family
ID=76470615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110278281.7A Active CN113024536B (zh) | 2021-03-12 | 2021-03-12 | 含嘧啶-哌嗪环的5-氨基噻唑甲酰胺类化合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113024536B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010139981A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
CN103429574A (zh) * | 2010-11-16 | 2013-12-04 | 阿塞蒂隆制药公司 | 作为蛋白质去乙酰化酶抑制剂的嘧啶羟基酰胺化合物和其使用方法 |
CN109265455A (zh) * | 2018-11-09 | 2019-01-25 | 新发药业有限公司 | 一种达沙替尼的制备方法 |
-
2021
- 2021-03-12 CN CN202110278281.7A patent/CN113024536B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010139981A2 (en) * | 2009-06-03 | 2010-12-09 | Generics [Uk] Limited | Processes for preparing crystalline forms |
CN103429574A (zh) * | 2010-11-16 | 2013-12-04 | 阿塞蒂隆制药公司 | 作为蛋白质去乙酰化酶抑制剂的嘧啶羟基酰胺化合物和其使用方法 |
CN109265455A (zh) * | 2018-11-09 | 2019-01-25 | 新发药业有限公司 | 一种达沙替尼的制备方法 |
Non-Patent Citations (1)
Title |
---|
鄢龙家等: ""1,3,4-噁二唑和1,3,4-噻二唑衍生物的设计、合成和生物活性研究"", 《有机化学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN113024536B (zh) | 2022-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105153122B (zh) | [(吲哚-3-基)嘧啶-2-基]氨基苯基丙-2-烯酰胺衍生物及盐、制备方法、应用 | |
RU2640417C2 (ru) | Стабильная кристаллическая форма типирацила гидрохлорида и способ ее кристаллизации | |
TW200406198A (en) | O-substituted hydroxyaryl derivatives | |
CN106432247B (zh) | 含有腙键的嘧啶并三氮唑类化合物、制备方法及其应用 | |
CN113200969B (zh) | 一种PI3Kα选择性抑制剂及其制备方法和应用 | |
CN107383004B (zh) | 2-氨基咪唑并吡啶类衍生物及制备和应用 | |
CN112010839B (zh) | 靶向丝/苏氨酸激酶抑制剂的晶型 | |
EP2269994B1 (en) | The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof | |
CN111704646B (zh) | 甾体类化合物及其制备方法和用途 | |
CN109761902B (zh) | 6-菲啶酮衍生物及其制备方法和用途 | |
CN117137919A (zh) | 一种氨基嘧啶衍生物及其作为egfr酪氨酸激酶抑制剂的应用 | |
CN113024536B (zh) | 含嘧啶-哌嗪环的5-氨基噻唑甲酰胺类化合物及其制备方法和用途 | |
CN103396386A (zh) | 双取代二萘并[2,1-b:1′,2′-d]呋喃类衍生物及其制备方法和应用 | |
CN110563657B (zh) | 一种1-(2,6-二氯苯基)-3-取代脲类结肠癌抑制剂及其制备和应用 | |
CN110357905B (zh) | 作为蛋白激酶抑制剂的大环类衍生物及其制备方法和用途 | |
CN116041277A (zh) | 苯基和联苯基取代的五元杂环类化合物及其制备方法、药物组合物和应用 | |
CN116120239A (zh) | 芳香六元环并咪唑类衍生物及其制备方法和应用 | |
US8729130B2 (en) | Methods of using novel solid forms of tacedinaline | |
CN116239603A (zh) | 一种2-氨基嘧啶杂环类化合物及其应用 | |
CN109705117A (zh) | 三环类化合物、其制备方法及用途 | |
CN114560845B (zh) | 喹啉化合物的晶型ɑ及其制备方法和应用 | |
CN112079836B (zh) | 三唑并嘧啶类化合物及其盐、组合物和应用 | |
CN110396066B (zh) | 一种1-(3,5-二甲氧基苯基)-3-取代脲类结肠癌抑制剂及其制备和应用 | |
RU2809821C2 (ru) | Соединения на основе триазолопиримидина и их соли, композиции на их основе и пути их применения | |
CN115109083B (zh) | Pyridostatin类化合物及其制备方法、应用、药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Jianbing Inventor after: Feng Xing Inventor after: Liu Yong Inventor after: Chen Yalu Inventor after: Mao Yuyin Inventor after: Fang Jing Inventor after: Luo Shurong Inventor before: Liu Jianbing Inventor before: Liu Yong Inventor before: Chen Yalu Inventor before: Mao Yuyin Inventor before: Fang Jing Inventor before: Luo Shurong |
|
GR01 | Patent grant | ||
GR01 | Patent grant |